期刊文献+

HPLC法控制丹参素异丙酯质量 被引量:2

Quality control of isopropyl β-(3,4-dihydroxyphenyl)-α-hydroxypropanoate by HPLC
下载PDF
导出
摘要 目的:建立以高效液相色谱法控制丹参素异丙酯质量的方法。方法:色谱柱为Agilent HC-C18柱(150 mm×4.6 mm,5μm),流动相为甲醇-0.2%甲酸水(30∶70),流速:0.8 mL/min,检测波长:284 nm,柱温:25℃,进样量:10μL。结果:丹参素异丙酯主峰与其他杂质峰分离良好,线性范围为5~500μg/mL(r=0.999 9);低、中、高3个浓度加样回收率(%)分别为100.03,100.87和100.27,RSD(%)分别为0.53,0.23和0.50。结论:该方法准确、灵敏、专属性好,可用于丹参素异丙酯的质量控制。 Aim: To establish an HPLC method for the determination of isopropyl β-(3, 4-dihydroxyphenyl) - α- hydroxypropanoate. Methods: Separation was achieved on an Agilent HC-C18column (150 mm × 4. 6 mm, 5 μm) with the mobile phase consisting of methanol-0. 2% formic acid ( 30 : 70), at a flow-rate of 0. 8 mL/min. The detection wavelength was set at 284 nm. The column oven temperature was 25 ℃. The injection volume was 10 μL Results: A good resolution with baseline separation was obtained. The calibration was linear in the range of 5-500 μg/mL (r =0. 999 9). The recoveries of three concentrations ( 10, 100,400 μg/mL) were 100. 03%, 100. 87% and 100. 27%, respectively; and the RSDs were 0. 53%, 0. 23% and 0. 50%, respectively. Conclusion: The developed method is accurate, sensitive and suitable for quality control of isopropyl β-( 3, 4-dihydroxy- phenyl)-α-hydroxypropanoate.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2009年第1期47-50,共4页 Journal of China Pharmaceutical University
基金 教育部科学技术研究重点资助项目(No.207151) 陕西省重大科技专项资助项目(No.2006KZ10-G5) 陕西省自然科学基金资助项目(No.2006C220)~~
关键词 丹参素异丙酯 含量测定 有关物质 高效液相色谱法 isopropyl β-( 3, 4-dihydroxyphenyl)-α-hydroxypropanoate determination of content related substances HPLC
  • 相关文献

参考文献7

二级参考文献23

  • 1于淼,于治国,高阳,赵云丽.当归寄生注射液指纹图谱研究[J].中成药,2004,26(8):607-610. 被引量:2
  • 2唐英,刘思曼,胡德斌,郭慧,张进,李方.反相高效液相色谱法测定川楝树皮中的川楝素[J].化学研究与应用,2005,17(2):276-278. 被引量:16
  • 3刘思曼,边清泉,唐英,张进,李方.RP-HPLC在线衍生法测定红景天中痕量铅的研究[J].化学研究与应用,2006,18(5):588-590. 被引量:2
  • 4钱名望 杨保津 等.丹参有效成分的研究[J].化学学报,1978,36(3):199-205.
  • 5郑虎占(Zheng HZ),董泽宏(Dong ZH),佘靖(She J).中药现代研究与应用[M].第2卷,北京:学苑出版社,1997:1 093-1 193.
  • 6国家药典委员会.WS-10001-(HD-0923)-2002.国家药品标准(试行):丹参酮ⅡA磺酸钠[S].
  • 7国家药典委员会.WS-10001-(HD-1014)-2002.国家药品标准:丹参酮ⅡA磺酸钠注射液[S].
  • 8Graul A,Castaner J.Repaglinide[J].Drugs Future,1996,21(7):694.
  • 9Balfour J A,Goa KL.Dolasetron:A review of its pharmacology and therapeutic potential in the management of nausea and vomiting induced by chemotherapy,radiotherapy or surgery[J].Drugs,1997,54(2):273.
  • 10The council of experts.USP28-NF23[S].第 28版.Washington.D.C:The Board of Trustees,2005:688.

共引文献43

同被引文献1961

  • 1LIU Shao-jing (刘少静).Study on structural characterization, quality control and pharmacokinetic of DBZ(DBZ的结构表征、质量控制及其药代动力学研究):.Shaanxi(陕西):Northwestern University(西北大学),2009.
  • 2ZHENG Xiao-hui(郑晓晖),ZHANG Qun-zheng(张群正),WANG Shi-xiang(王世祥),et al.β-(3,4-dihydroxyphenyl)-α-hydroxy acid borneol esters,synthesis and use(β-(3,4-二羟基苯基)-α-羟基丙酸冰片酯、其合成方法和用途).CN:006004787,2006-9.
  • 3ChP(中国药典).2005.Vol Ⅱ(二部):Appendix(附录)7.
  • 4State Food and Drug Administration(国家食品药品监督管理局).Technical Guidelines for Drug Research(药物研究技术指导原则).Beijing(北京):China Medico-Pharmaceutical Science and Technology Publishing House(中国医药科技出版社),2005.,50.
  • 5SUN Hao(孙浩),JIANG Su-mei(蒋素梅),GU Ping(顾萍),et al.Determination of repaglinide and the related substances in repaglinide and its tablets by HPLC(HPLC法测定瑞格列奈原料药及其片剂中主药和有关物质的含量).China Pharm (中国药房),2007,8(9):1496.
  • 6YAO Jing(姚静),ZHANG Qi-ming(张启明),LI Zhuo-rong(李卓荣),et al.HPLC determination of repaglinide tablets(高效液相色谱法测定瑞格列奈片的含量).Chin J Pharm Anal(药物分析杂志),2007,7(5):78.
  • 7Liu D,Gao YW,Wang HJ,et al.Evaluation of the effects of cytochrome P450 nonsynonymous single-nucleotide polymorphisms on Tanshinol Borneol Ester metabolism and inhibition potential.Drug Metab Dispos,2010,38(1):2259.
  • 8孙国祥,纪宏,于秀明.知母HPLC指纹图谱的4种相似度评估[J].中成药,2008,30(1):1-6. 被引量:11
  • 9顾英,冯怡,徐德生.芍药甘草效应组分血清指纹图谱与药效的相关性研究[J].中成药,2008,30(1):6-10. 被引量:18
  • 10丁霞,余宗亮,杜伟峰,蔡宝昌.SP825-大孔树脂富集山茱萸环烯醚萜苷的工艺研究[J].中成药,2008,30(1):53-56. 被引量:9

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部